Genmab A/S

  • Market Cap: N/A
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: DK0010272202
DKK
2,062.00
39 (1.93%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationCash Flow
Genmab A/S Cash flow Statement
Figures in Million
Consolidated Cash Flow Results
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
No of Months
12
12
12
12
12
12
Profit Before Tax
9,164.00
5,637.00
6,945.00
3,983.00
5,904.00
2,859.00
Adjustment
0.00
0.00
0.00
0.00
0.00
0.00
Changes In working Capital
-738.00
1,362.00
-1,840.00
-770.00
987.00
-1,218.00
Cash Flow after changes in Working Capital
0.00
0.00
0.00
0.00
0.00
0.00
Cash Flow from Operating Activities
7,771.00
7,380.00
3,912.00
2,228.00
6,433.00
1,326.00
Cash Flow from Investing Activities
-9,907.00
-1,282.00
-2,761.00
-961.00
-2,351.00
-1,983.00
Cash Flow from Financing Activities
-3,919.00
-606.00
-789.00
-420.00
71.00
3,660.00
Net Cash Inflow / Outflow
-5,009.00
4,974.00
936.00
1,697.00
3,708.00
3,019.00
Opening Cash & Cash Equivalents
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
0.00
0.00
0.00
0.00
0.00
Translation adjustment on reserves / op cash balances foreign subsidiaries
0.00
0.00
0.00
0.00
0.00
0.00
Effect of Foreign Exchange Fluctuations
1,046.00
-518.00
574.00
850.00
-445.00
16.00
Closing Cash & Cash Equivalent
0.00
0.00
0.00
0.00
0.00
0.00
Figures in DKK Million
Seasonal companies are compared with the same quarter last year
Compare Cash Flow Results of Genmab A/S
Markets Mojo
Figures in Million
consolidated Cash Flow Results
Markets Mojo
Markets Mojo
Change(DKK)
Change(%)
Profit Before Tax
9164
127208
-1,18,044.00
-92.80%
Adjustment
0
0
0.00
0.00%
Changes In working Capital
-738
-11995
11,257.00
93.85%
Cash Flow after changes in Working Capital
0
0
0.00
0.00%
Cash Flow from Operating Activities
7771
120968
-1,13,197.00
-93.58%
Cash Flow from Investing Activities
-9907
-128895
1,18,988.00
92.31%
Cash Flow from Financing Activities
-3919
8735
-12,654.00
-144.87%
Net Cash Inflow / Outflow
-5009
1263
-6,272.00
-496.60%
Opening Cash & Cash Equivalents
0
0
0.00
0.00%
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0
0
0.00
0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations
0
0
0.00
0.00%
Translation adjustment on reserves / op cash balances foreign subsidiaries
0
0
0.00
0.00%
Effect of Foreign Exchange Fluctuations
1046
455
591.00
129.89%
Closing Cash & Cash Equivalent
0
0
0.00
0.00%
Cash Flow - Snapshot (Consolidated) - Dec'24
stock-summary

YoY Growth in year ended Dec 2024 is 5.30% vs 88.65% in Dec 2023

Dec'24
Dec'23
Change(%)
Cash Flow from Operating Activities
7,771.00
7,380.00
5.30%